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original scientific paper 
Summary 
 
Nutrition and the intake of necessary nutrients is the basic need of every organism and indispensable for normal functioning of every 
living creature. The problem arises if there are constraints or inability to adequately take in food to meet all the nutritive needs of the 
organism and thus the risk of the development of malnutrition. In such situations, enteral nutrition practices are often used as an artificial 
feeding method, and if the need for such nutritional support is longer-lasting, it is advisable to set an indication for placement of 
percutaneous endoscopic gastrostomy (PEG) as one of the most effective ways of enteral nutrition. This is the procedure where a 
specially adapted probe is placed through the abdominal wall directly into the stomach. Applications are numerous, and given that this is 
a long-term artificial nutrition method, it is most often used in chronic, neurological or oncological patients. The aim of this paper is to 
demonstrate the importance of adequate enteral nutrition as the main segment in prevention and treating malnutrition. In particular, 
specificities of enteral diet via PEG are presented as the most effective and safest method of artificial nutrition, which is accompanied by 
the results of the monthly monitoring of the nutritional status and the manner of feeding, as well as the clinical status of the person with 
PEG. In this case report results were compared before and after implantation of PEG. 
 




The importance of optimal nutrition has been declared 
since the time of the Hippocrates, who said that "medical 
science would not have been discovered or found and 
would not become the subject of research if the same 
dish and drink were appropriate to a sick and healthy 
man" (Živković, 2002). In patients who cannot eat 
enough or at all orally to satisfy all the nutritional needs 
of the organism for macronutrients and micronutrients, 
we turn to enteral diet, as you can see in Fig. 1  




Fig. 1. The feeding options depending on nutrition status of patient, scheme (De Bruyne et al., 2008) 
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This enteral diet involves the intake of food and/or 
commercial nutrient supplement using nutritional 
probes in stomach, duodenum or jejunum. In Fig. 2 
and Fig. 3 the percutaneous endoscopic 










Fig. 3. Feeding by percutaneous endoscopic gastrostomy (author, 2018) 
 
 
There is a possibility of parenteral nutrition for these 
patients, but almost always when it is possible, the 
advantage is in the enteral feeding mode. The main 
precondition is structurally (at least 100 cm of small 
intestine) and a functional digestive system 
(Krznarić, 2006), and the main postulate of clinical 
nutrition today is: "If the intestine is in function, use 
it (Štimac et al., 2014)". Today, a wide range of 
finished enteral preparations is available, which can 
be used by oral intake, but also can be applied by 
different types nazoenteral tubes via percutaneous 
endoscopic gastrostoma (PEG) (Blumenstein et al., 
2014). Numerous studies that validated enteral 
nutrition by nasogastric probes and PEG, gave PEG 
superiority, as it provides greater nutrition energy 
utilization and preserving albumin levels a longer 
period of time (Zalar et al., 2004; Kumagai et al., 
2012; Cristian et al., 2015). PEG is a safe method 
with a lower risk of aspiration and aspiration 
pneumonia and is associated with a higher survival 
rate (Kumagai et al., 2012). The use of nasogastric 
probe is associated with a greater number of 
complications and greater need for re-insertion of the 
probe (Blumenstein et al., 2014). One of the studies, 
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comparing the patients with nasogastric probe and 
patients with PEG, shows that there is three times the 
probability of aspiration pneumonia in patients with 
nasogastric probe (Azzopardi and Ellul, 2013). Older 
age, neurological disorders and cerebrovascular 
diseases also increase the risk of aspiration 
pneumonia (Patel and Thomas, 1990). Except from 
hospitalized patients, PEG can be applied at home – 
Home Enteral Tube Feeding (HETF), which has been 
steadily increasing over the past few years (Ojo, 
2012; Madigan et al., 2002). One of the most 
common reasons for introducing enteral nutrition is 
malnutrition, which is defined as a nutritional status 
disorder due to reduced or excessive intake of 
nutrients (Cederholm et al., 2019; Živković, 2002). 
The first step in evaluation of nutritional status of 
patients and detect individuals with a tendency to 
develop nutritional deficit / malnutrition is 
malnutrition risk screening. It is a simple and fast 
procedure using the one of a validated screening tool 
known as Nutritional Risk Screening (NRS, 2002) 
(Kondrup et al., 2003). The final diagnosis of 
malnutrition is defined by clinical examination 
according to the Cederholm et al. (2019), anamnestic 
and heteroanamnestic data of the patient and several 
diagnostic criteria such as unintended weight loss, 
low BMI, inadequate food intake, loss of muscle 
mass and low FFMI (Fat Free Mass Index). 
Calculation of BMI is based on body mass and body 
height; BMI is the body mass ratio in kilograms and 
body height in meters and it is the indicator of the 
degree of nutrition. (WHO, 2019) Values of 
recommended BMI are the same for both sexes, 
ranging from 18.5 to 24.9 kg / m2 according to the 
World Health Organization's Classification for the 
European Population. 
Any unintended change in body mass is important and 
the cause must be determined. Loss of 5% of body 
weight indicates a mild, and more than 10% of a serious 
nutritional and health problem (Štimac et al., 2014). If 
an enteral diet is planned for more than three weeks or if 
there are conditions in the patient status that include 
disabled swallowing and food intake due to 
oropharyngeal and esophagus dysfunction / stenosis / 
obstruction, PEG insertion is the main priority. If there 
is no local tissue reaction, such as redness, swelling or 
nausea, diarrhea, vomiting, abdominal pain and cramps, 
after localization of PEG, the planned dietary enteral 
diet can be started after 24 hours after the PEG 
implementation. In hospitals and clinics, patients are 
educated about care of PEG, feeding by PEG and other 
relevant data. After they go home, the multidisciplinary 
team of primary health care provides necessary support, 
although the necessary clinical control and evaluation of 
PEG (Madigan et al., 2002). 
Methods 
 
In this paper it is used the case study method. It is 
used the analysis of documents, interviews of 
medical staff and observation. Since it was a person 
with mental disabilities, the informative written 
consent to the study and the publication of the work 
was given by the legal guardian of the patient. In the 




N.N. is female, 54 years old, lives in Home for 
persons with physical, intellectual or sensory 
disability. Her diagnoses are psychomotor 
retardation, secondary epilepsy and secondary 
dysphagia with implanted percutaneous endoscopic 
gastro stoma on October 13, 2016. She has a history 
of hypothyroidism, osteoarthritis, and thoracolumbar 
scoliosis. 
 
Status (November 2017) 
 
In consciousness, partially oriented, poor verbal contact 
according to the nature of the illness (provides only 
basic information about herself, whether yes or not), 
immobile, all physiological needs are performed in bed 
with the maximum help of medical staff, slowed down, 
the muscular strength of both arms reduced. Body 
height 174 cm, body weight 62.7 kg. In the previous 
months there was a constant decrease in body weight 
(Fig. 4). From heteroanamnestic data of a nurse from 
her home, it is known that the person is otherwise calm, 
cooperative, occasionally has epilepsy attack and 
because of these she has been hospitalized several times 
at University Hospital Centre where she takes regularly 
control at the Center for Epilepsy. 
 
Clinical status and course of treatment 
 
From her medical documentation (March, 2015) she 
was hospitalized several times in the General 
Hospital due to repeating aspiration pneumonia with 
acute respiratory insufficiency, poorly general 
condition and somnolence. She was mainly fed per os 
with the porridges and hydrated by tea or water. 
During hospitalization she was fed by a nasogastric 
probe. This method is continued by releasing home 
until the satisfactory oral intake. The tube was 
occasionally placed during noncooperation and food 
rejection. In diet are introduced enteral supplements 
(4 x 200 mL = 1000 kcal) plus hydration / water / tea 
/ juice (1000 mL) by using a bolus feeding method. 
 
 





Fig. 4. Body mass (BM) tracking from 3/2015 to 10/ 2016, the red line indicates loss of 10 %  
of body weight (author, 2018) 
 
When she was placed to Homefor persons with physical, intellectual or sensory disability, her body weight at the beginning 
of March 2015 was 97.6 kg (BMI 32.2 kg/m2 - 1st degree of obesity) and after first hospitalization at the end of March was 
94 kg (BMI 31 kg/m2 - 1st degree of obesity). Further data on body mass were obtained from a home monitoring list whose 
measurements were carried out every two months according to their own regular protocol. According to the Fig. 4 from 
March 2015 to September 2016, there is a permanent loss in body weight. The total weight loss in the 19-month period was 
25.3 kg, which is a loss of almost 26% of the total body mass. The patient was predominantly fed per os with porridges and 
by nasogastric probe performed by nurse. According to body weight monitoring results, such an intake did not satisfy the 
nutritional needs of the body. Visible continuous loss of body mass, risk of continuity of the same and development of 
protein energy malnutrition (PEM), relapses of aspiration pneumonia, increasingly severe oral deficiency, to a person for 
the purpose of ensuring long-term enteral intake, on October 13, 2016 was implanted percutaneous endoscopic gastrostoma, 
Freka PEG 20 Fr, and on February 9, 2018, a person receives a transmissible pump for enteral nutrition with associated 




Fig. 5. Body mass tracking by PEG insertion until March 2018, the redline indicates loss  
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Body mass in October 2016 was 72.3 kg. After the PEG 
implantation and patient return from hospital on October 
14, 2016, the body weight was 72 kg (BMI 23.8 kg/m2 - 
normal body weight). The total weight loss from PEG 
implantation up to March 2018, for 17 months, was 11.4 
kg, which is 15.7 % of total body mass (Fig. 5). 
 
Discussion and conclusion 
 
According to Fig. 6 and Fig. 7, there is a continuous body mass deficiency, but comparing the figures it is important to point 
out the difference in body mass loss that significantly deviates. Before the PEG implantation, a person lost 25.3 kg (26%) in 
the 19-month period. The weight loss ranged from 0.6 kg to 5.8 kg with the highest losses after hospitalization with an 
average loss of 2.3 kg. After PEG implantation, there is still a noticeable decrease in body weight although for a shorter 
period of time, namely 17 months, but a significantly smaller one. The weight loss was 11.4 kg or 15.7%. The weight loss 
range was from 0.3 kg to 5.9 kg with an average loss of 1.3 kg but also with one positive result of +1.3 kg. The biggest loss 
of 5.9 kg was recorded in April 2017 due to the lack of adequate nutritional support regarding the clinical condition of a 
person - she had consecutive grand mal attacks a few days in row. By providing adequate nutritional support via PEG, loss 
of body weight was reduced and decreased, risk of dehydration decreased and she was not hospitalized by aspiration 
pneumonia or respiratory insufficiency as it was the case when she was fed per os or by nasogastric probe. The greatest 
body weight loss is visible due to hospitalization which has been reduced after the PEG has been set up. This body weight 
differences is not strange since it has also been proven in research that include amyotrophic lateral sclerosis patients who 
were fed by PEG (Mazzini et al., 1995). 
 
 




Fig. 7. Comparison between body weight differences before and after the implementation of PEG (author, 2018) 
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The importance of adequate accommodation in the 
home, adequate health care and care by an expert, 
educated staff, as well as adequate, individual access, 
personalized communication with a person with an 
existing cognitive deficit provided by nurses has to 
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